RZLT
Rezolute Inc

850
Loading...
Loading...
News
all
press releases
Futures Drop, Yields Jump On Red-Hot UK Inflation, Nvidia Earnings On Deck
Futures Drop, Yields Jump On Red-Hot UK Inflation, Nvidia Earnings On Deck US futures are lower on Nvidia day; with the stock down 56bps in premarket trading, while Mag7 and semis are...
Zero Hedge·1y ago
News Placeholder
More News
News Placeholder
Rezolute, Inc. (NASDAQ:RZLT) Insider Brian Kenneth Roberts Buys 10,000 Shares
Rezolute, Inc. (NASDAQ:RZLT Get Free Report) insider Brian Kenneth Roberts acquired 10,000 shares of the stock in a transaction on Thursday, March 14th. The shares were purchased at an...
Ticker Report·1y ago
News Placeholder
Reviewing Rezolute (NASDAQ:RZLT) & SCYNEXIS (NASDAQ:SCYX)
Rezolute (NASDAQ:RZLT Get Free Report) and SCYNEXIS (NASDAQ:SCYX Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two...
Zolmax·1y ago
News Placeholder
Rezolute, Inc. (NASDAQ:RZLT) CFO Daron Evans Acquires 50,000 Shares
Rezolute, Inc. (NASDAQ:RZLT Get Free Report) CFO Daron Evans purchased 50,000 shares of the stock in a transaction on Friday, March 8th. The shares were purchased at an average cost of $1.93...
Zolmax·1y ago
News Placeholder
Daron Evans Acquires 50,000 Shares of Rezolute, Inc. (NASDAQ:RZLT) Stock
Rezolute, Inc. (NASDAQ:RZLT Get Free Report) CFO Daron Evans purchased 50,000 shares of the companys stock in a transaction that occurred on Friday, March 8th. The shares were...
Ticker Report·1y ago
News Placeholder
Rezolute (NASDAQ:RZLT) Stock Rating Reaffirmed by HC Wainwright
Rezolute (NASDAQ:RZLT Get Free Report)s stock had its buy rating reaffirmed by HC Wainwright in a report released on Thursday, Benzinga reports. They presently have a...
Zolmax·1y ago
News Placeholder
Rezolute Reports Validation of the Potential Use of RZ358 for Treatment of Non-Islet Cell Tumor Hypoglycemia (NICTH)
Potential to more than double the addressable patient population living with hypoglycemia resulting from insulin receptor over-activation (tumor hyperinsulinism) Effects of RZ358 on Ligand-Induced...
Globe Newswire·2y ago
News Placeholder
Rezolute (NASDAQ:RZLT) Stock Rating Reaffirmed by HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Rezolute (NASDAQ:RZLT Free Report) in a report released on Wednesday, Benzinga reports. HC Wainwright currently has a $14.00 price...
Ticker Report·2y ago
News Placeholder
Rezolute (NASDAQ:RZLT) Receives "Buy" Rating from HC Wainwright
Rezolute (NASDAQ:RZLT Get Free Report)s stock had its buy rating restated by HC Wainwright in a report issued on Wednesday, Benzinga reports. They presently have a $14.00...
Zolmax·2y ago
News Placeholder
Rezolute, Inc. (NASDAQ:RZLT) Shares Could Be 31% Above Their Intrinsic Value Estimate
Key Insights Rezolute's estimated fair value is US$0.87 based on 2 Stage Free Cash Flow to Equity Rezolute's US$1.14...
Simply Wall St·2y ago

Latest RZLT News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.